Definium Therapeutics, Inc. (DFTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Definium Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.51x | -4.51x | -1.50x | -1.20x | -6.09x | -23.81x |
| P/B Ratio | 3.60x | 2.03x | 1.83x | 0.45x | 3.74x | 10.70x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.29x | 7.25x | 3.22x | 8.16x | 13.18x | 27.10x |
| Quick Ratio | 6.29x | 7.25x | 3.22x | 8.16x | 13.18x | 27.10x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.09x | 0.18x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..